NCT02100891 2025-03-19
STIR
Medical College of Wisconsin
Phase 2 Terminated
Clinical Trials
8 trialsNCT03448978 2024-07-01
Autologous CD8+ T-cells Expressing an Anti-BCMA CAR in Patients With Myeloma
Cartesian Therapeutics
Phase 1 Terminated
NCT02664363 2023-02-17
ExCeL
Duke University
Phase 1 Terminated
NCT01685606 2022-03-04
273
Brown University
Phase 2 Terminated
NCT04097301 2022-01-19
Study of CAR T-cell Therapy in Acute Myeloid Leukemia and Multiple Myeloma
AGC Biologics S.p.A.
Phase 1/2 Terminated
NCT02757391 2020-10-30
CD8+ T Cell Therapy and Pembrolizumab in Treating Patients With Metastatic Gastrointestinal Tumors
M.D. Anderson Cancer Center
Phase 1 Terminated
NCT01239368 2019-12-10
Th1/Tc1 Immunotherapy Following Stem Cell Transplantation in Multiple Myeloma
National Institutes of Health Clinical Center (CC)
Phase 1/2 Terminated
NCT03431311 2019-06-13
TCR-CRC-001
Oslo University Hospital
Phase 1/2 Terminated